Potsdam Meeting 2017
Retinal degeneration
Potsdam Meeting 2017
Retinal degeneration
Interface GmbH & Co. KG
Frau Hanna Krämer
Postfach 0455
97301 Kitzingen
Tel.: +49 (0)9321 390 73 14 (Durchwahl)
Fax: +49 (0)9321 390 73 99
E-Mail: kraemer@interface-congress.de
-
Basisinformation
Datum07.04.2017, 13:00 - 08.04.2017, 13:00FortbildungPotsdamSpracheEnglischGebühren ab90.00 EURVeranstalterPRO RETINA Deutschland e.V.
OrganisatorInterface GmbH & Co. KG
Frau Hanna Krämer
Postfach 0455
97301 Kitzingen
Tel.: +49 (0)9321 390 73 14 (Durchwahl)
Fax: +49 (0)9321 390 73 99
E-Mail: kraemer@interface-congress.de -
VERANSTALTUNGSORT
Seminaris SeeHotel Potsdam
An der Pirschheide 40
14471 Potsdam, DE -
Programm
Friday, April 7, 2017
13:05 - 14:30 - Session 1 - Selected Poster Presentations - 8 abstracts to be selected14:30 - 15:00 - Keynote Lecture - Learning from the zebrafish: regeneration of the retina is possible - but how does it work?
15:45 - 17:25 - Session 2 - Modifying disease processes
15:45 - 16:10 - Personalized therapeutic strategies for patients with retinitis pigmentosa
16:10 - 16:35 - The role of microRNAs in the human retina
16:35 - 17:00 - Long non-coding RNA in development and disease
17:00 - 17:25 - Targeting cGMP-signaling in inherited retinal degeneration
19:00 - 20:00 - Session 3 - Of men and mice in science
19:00 - 19:30 - Hereditary retinal disorders: A pioneering field in biological research
19:30 - 20:00 - The rd mouse - a long story"
20:00-open - Swingin' Poster Session
Saturday, April 8, 201709:00 - 10:40 - Session 4 - An update on disease mechanisms
09:00 - 09:25 - 12 years after: The search for complement inhibitors in AMD
09:25 - 09:50 - Complement Factor H controls macrophage life-span
09:50 - 10:15 - The NLRP3 inflammasome - new therapeutic target in macular degeneration
10:15 - 10:40 - Mode of action of RdCVF and its origin
11:15 - 12:55 - Session 5 - Innovative approaches to translation
11:15 - 11:40 - Visualization of specific DNA sequences in living mouse embryonic stem cells with a programmable fluorescent CRISPR/Cas system.11:40 - 12:05 - Regeneration of complex multi-tissue structures
12:05 - 12:30 - CRISPR/Cas9 Genome Surgery to Eliminate Dominant Negative Disease
12:30 - 12:55 - Envisioning a Gene Editing Approach to Treat Inherited Blindness
-
Gebühren
Fachärzte/-innenGebühren ab140,00 EURÄrzte/-innen in WeiterbildungGebühren ab120,00 EURStudenten/-innenGebühren ab90,00 EUR
-
Buchung / Anmeldung
Anmeldung erbeten. Bitte wenden Sie sich für weitere Informationen direkt an den Veranstalter.
-
Zertifizierung
Keine Zertifizierung beantragt
- Sponsoren